Radiodermatitis
Conditions
Interventions
This is a randomized, single-blind clinical trial conducted with women diagnosed with breast cancer and undergoing three-dimensional conformal radiotherapy (3DRT) between March and September 2024, at
Sponsors
Coordenação de Cursos de Pós-Graduação Lato Sensu e Extensão da Escola de Saúde Pública do Distrito Federal (Fepecs)
Hospital de Base do Distrito Federal - Instituto de Gestão Estratégica de Saúde do Distrito Federal
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: women; over 18 years of age; with a histological diagnosis of breast cancer; undergoing conservative surgery or mastectomy; with or without reconstruction; scheduled for adjuvant radiotherapy; availability to attend before or after the radiotherapy session; sign the Free and Informed Consent Form (FICF)
Exclusion criteria
Exclusion criteria: mentally incapable of answering questions about their health;undergoing radiotherapy due to recurrence of the disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: The prior application of photobiomodulation in women diagnosed with breast cancer and undergoing radiotherapy will present results in the prevention of radiodermatitis. This may be null or to a lesser extent when comparing the intervention group using LED and the control group.;Outcome found: The partial results showed that in the 16 volunteers included (control = 9 and treatment = 7), the degree of radiodermatitis in the breast plastron was less frequent in the FBM group compared to the control group (12.6% vs. 50% - p=0.015). | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes were expected. | — |
Countries
Brazil
Contacts
Public ContactNatália Vieira
Hospital de Base do Distrito Federal - Instituto de Gestão Estratégica de Saúde do Distrito Federal
Outcome results
None listed